just a note from previous fin report...
"Revenues from the sale of ReCell rose by 61% in FY11 compared to FY10"
Also note that during the last quarter we had the following:
Sep 11 - JV in Middle East and Africa
Oct 11 - launch of treatment of chronic ulcers
Dec 11 - Expansion into Italy
So alot more to come yet and I'm expecting an exponential rise in saes as new geographic JV's take hold.
All good
maddoc
avita medical reports strong half year financi, page-9
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.84 |
Change
-0.120(3.03%) |
Mkt cap ! $268.3M | |||
| Open | High | Low | Value | Volume |
| $3.94 | $3.94 | $3.76 | $511.0K | 134.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.84 | 11883 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |